title: Asymptomatic papulonodular lesions in zosteriform distribution in an immunocompromised patient.
authors.affiliation: Department of Dermatology, Fattouma Bourguiba University Hospital, Monastir, Tunisia. monia.youssef@gmail.com.
authors.forename: Monia
authors.initials: M
authors.lastname: Youssef
authors.affiliation: Department of Dermatology, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
authors.forename: Mouna
authors.initials: M
authors.lastname: Korbi
authors.affiliation: Department of Anatomopathology, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
authors.forename: Faten
authors.initials: F
authors.lastname: Hammedi
authors.affiliation: Department of Nephrology, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
authors.forename: Habib
authors.initials: H
authors.lastname: Skhiri
authors.affiliation: Department of Dermatology, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
authors.forename: Hichem
authors.initials: H
authors.lastname: Belhadjali
authors.affiliation: Department of Dermatology, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
authors.forename: Jameleddine
authors.initials: J
authors.lastname: Zili
mesh_terms: D000328:Adult; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D008297:Male; D012514:Sarcoma, Kaposi / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus